WHO/FDA registered Antimalarial, Pyramax approved for Coronavirus clinical trials
The World Health Organization prequalified and Ghana Food and Drugs Authority registered Antimalarial Pyramax (Artesunate-Pyronaridine), a fixed-dose combination medication for ...